Recent developments in the pathogenesis, diagnosis and treatment of celiac disease

Expert Opinion on Therapeutic Patents

Volumn 12, Issue 1, 2002, Pages 45-51

  Drago, S ^a   Di Pierro, M ^a   Catassi, C ^a   Fasano, A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Anti endomysium antibodies; Anti gliadin antibodies; Anti tissue transglutaminase antibodies; Gluten; Gluten free diet; HLA

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CYTOKINE ANTIBODY; ENDOMYSIUM ANTIBODY; EPITOPE; FAS ANTIBODY; GAMMA INTERFERON; GLIADIN; GLIADIN ANTIBODY; GLUTEN; HLA DQ ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; LACTASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M 110; MONOCLONAL ANTIBODY M 111; NEUTRALIZING ANTIBODY; PROLAMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGE; ANTIGEN RECOGNITION; ANTIGENICITY; BARLEY; CELIAC DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; INTESTINE BIOPSY; PATENT; REVIEW; RYE; SMALL INTESTINE MUCOSA;

EID: 0036137618     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.12.1.45     Document Type: Review

References (41)

1. Approaches to diagnosis and treatment of celiac disease: An evolving spectrum
2. Current concepts of celiac disease pathogenesis
3. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis
4. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer
5. The foreign antigen binding site and T-cell recognition regions of class I immunohistocompatibility antigens
6. Histopathology of intestinal inflammation related to reactive arthritis
7. Identification of tissue transglutaminase as the autoantigen of celiac disease
8. Role to tissue transglutaminase in celiac disease
9. Coeliac disease in the year 2000: Exploring the iceberg
10. Sub-clinical coeliac disease
11. High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies
12. Increasing incidence of coeliac disease in Sweden
13. Undiagnosed coeliac disease is common in Finnish adults
14. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects
15. Epidemiology of Celiac Disease
16. Prevalence of celiac disease among risk groups and the general population in USA
17. Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors
18. Prevalence of celiac disease among blood donors in Brazil
19. Why is coeliac disease endemic in the people of the Sahara
20. Sideropenic anemia and celiac disease: One study, two points of view
21. Short stature as the primary manifestation of coeliac disease
22. Idiopathic cerebellar ataxia associated with celiac disease: Lack of distinctive neurological features
23. The clinical pattern of subclinical/silent celiac disease: An analysis on 1026 consecutive cases
24. Clinical and pathological spectrum of coeliac disease- active, silent, latent, potential
25. Human recombinant tissue transglutaminase ELISA: A powerful mass screening diagnostic assay for symptomatic and asymptomatic coeliac disease
26. Structural abnormalities of jejunal epithelial cell membranes in celiac sprue
27. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue
28. Human zonulin, a potential modulator of intestinal tight junctions
29. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease
30. Duration of exposure to gluten and risk for autoimmune disorders in celiac patients
31. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease
32. The precipitating factor in coeliac disease
33. In vitro assessment of acetic acid-soluble proteins (glutenin) in celiac disease
34. Identification of a putative motif for binding of peptides to HLA-DQ2
35. Autoantibodies in coelic disease: Tissue tranglutaminase-guilt by association?
36. A major role of matrix metalloproteinases in T cell injury in the gut
37. Tissue transglutaminase autoantibodies in patients with non-Hodgkin lymphoma. Case reports
38. Diagnostic accuracies for celiac disease of four tissue transglutaminase autoantibody tests using human antigen
39. Mortality in patients with coeliac disease and their relatives: A cohort study
40. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
41. Interleukin 15 mediates epithelial changes in celiac disease